Skip to Main Content

Paper Details

The relationship between the number of available therapeutic options and government payer (medicare part D) spending on topical drug products.
Arch Dermatol Res
3
2020
Author NameAffiliation
Leah J WeltyNorthwestern University Feinberg School of Medicine
  • 1 - 1

Datasets

Release 1.2